Tokyo, Oct. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058863) titled 'A study on colonic drug delivery' on Oct. 1.
Study Type:
Observational
Primary Sponsor:
Institute - Ajinomoto Co., Inc.
Condition:
Condition - obesity and type 2 diabetes
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - Indole-3-propionic acid, a tryptophan metabolite by gut bacteria, is known to have ameliorative effects on obesity and type 2 diabetes. Therefore, the aim of this study is to elucidate the optimal formulation design to deliver tryptophan to the colon.
Basic objectives2 - PK,PD
Eligibility:
Age-lower limit - 20
years-old
=
Gender - Male
Key inclusio...